Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$71.83 - $95.48 $10.6 Million - $14.1 Million
-147,879 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$67.0 - $84.39 $9.91 Million - $12.5 Million
147,879 New
147,879 $10.8 Million
Q3 2020

Nov 02, 2020

SELL
$55.23 - $79.93 $4.46 Million - $6.45 Million
-80,681 Closed
0 $0
Q2 2020

Aug 03, 2020

SELL
$30.2 - $56.98 $1.81 Million - $3.41 Million
-59,847 Reduced 42.59%
80,681 $4.48 Million
Q1 2020

May 12, 2020

BUY
$24.87 - $38.56 $1.08 Million - $1.68 Million
43,505 Added 44.84%
140,528 $4.16 Million
Q4 2019

Jan 31, 2020

BUY
$25.43 - $36.67 $2.47 Million - $3.56 Million
97,023 New
97,023 $3.51 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jabodon Pt CO Portfolio

Follow Jabodon Pt CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

News

Stay updated on Jabodon Pt CO with notifications on news.